Cargando…

Bacillus clausii for the Treatment of Acute Diarrhea in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Acute diarrhea is a burdensome disease with potentially harmful consequences, especially in childhood. Despite its large use in clinical practice, the efficacy of the probiotic Bacillus clausii in treating acute childhood diarrhea remains unclear. Our objective was to systematically review the effic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ianiro, Gianluca, Rizzatti, Gianenrico, Plomer, Manuel, Lopetuso, Loris, Scaldaferri, Franco, Franceschi, Francesco, Cammarota, Giovanni, Gasbarrini, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116021/ https://www.ncbi.nlm.nih.gov/pubmed/30103531 http://dx.doi.org/10.3390/nu10081074

Ejemplares similares

The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2020)

Fecal Microbiota Transplantation in Inflammatory Bowel Disease: Beyond the Excitement
por: Ianiro, Gianluca, et al.
Publicado: (2014)

Bacteriocins and Bacteriophages: Therapeutic Weapons for Gastrointestinal Diseases?
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2019)

Effect of Bacillus clausii Capsules in Reducing Adverse Effects Associated with Helicobacter pylori Eradication Therapy: A Randomized, Double-Blind, Controlled Trial
por: Plomer, Manuel, et al.
Publicado: (2020)

Role of Microbiota and Innate Immunity in Recurrent Clostridium difficile Infection
por: Bibbò, Stefano, et al.
Publicado: (2014)

Correction to: Effect of Bacillus clausii Capsules in Reducing Adverse Effects Associated with Helicobacter pylori Eradication Therapy: A Randomized, Double-Blind, Controlled Trial
por: Plomer, Manuel, et al.
Publicado: (2020)

The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease
por: Holleran, Grainne, et al.
Publicado: (2017)

Commensal Clostridia: leading players in the maintenance of gut homeostasis
por: Lopetuso, Loris R, et al.
Publicado: (2013)

Bacteremia after Bacillus clausii administration for the treatment of acute diarrhea: A case report
por: García, Juan Pablo, et al.
Publicado: (2021)

A Durum Wheat Variety-Based Product Is Effective in Reducing Symptoms in Patients with Non-Celiac Gluten Sensitivity: A Double-Blind Randomized Cross-Over Trial
por: Ianiro, Gianluca, et al.
Publicado: (2019)

Pre- and Posttherapy Assessment of Intestinal Soluble Mediators in IBD: Where We Stand and Future Perspectives
por: Scaldaferri, F., et al.
Publicado: (2013)

Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study
por: Ianiro, Gianluca, et al.
Publicado: (2020)

The respiratory chains of four strains of the alkaliphilic Bacillus clausii
por: Abbrescia, A., et al.
Publicado: (2014)

Antibiotic Sensitivity of Bacillus clausii Strains in Commercial Preparation
por: Abbrescia, A., et al.
Publicado: (2014)

Current Progress and Future Perspectives on the Use of Bacillus clausii
por: Ghelardi, Emilia, et al.
Publicado: (2022)

Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2023)

How to Face the Advent of SARS-CoV-2 Vaccination in IBD Patients: Another Task for Gastroenterologists
por: Papa, Alfredo, et al.
Publicado: (2021)

Bacillus clausii for Gastrointestinal Disorders: A Narrative Literature Review
por: Acosta-Rodríguez-Bueno, Carlos Patricio, et al.
Publicado: (2022)

Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis
por: Lopetuso, Loris R, et al.
Publicado: (2012)

Gut Microbial Flora, Prebiotics, and Probiotics in IBD: Their Current Usage and Utility
por: Scaldaferri, Franco, et al.
Publicado: (2013)

Can We Predict the Efficacy of Anti-TNF-α Agents?
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2017)

Comparative secretome analysis of four isogenic Bacillus clausii probiotic strains
por: Lippolis, Rosa, et al.
Publicado: (2013)

Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2020)

Blends of Carbohydrate Polymers for the Co-Microencapsulation of Bacillus clausii and Quercetin as Active Ingredients of a Functional Food
por: Saavedra-Leos, María Z., et al.
Publicado: (2022)

Novel trends with biologics in inflammatory bowel disease: sequential and combined approaches
por: Privitera, Giuseppe, et al.
Publicado: (2021)

Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center
por: Ianiro, Gianluca, et al.
Publicado: (2021)

Therapeutic efficacy of probiotic Alkalihalobacillus clausii 088AE in antibiotic-associated diarrhea: A randomized controlled trial
por: Maity, Chiranjit, et al.
Publicado: (2021)

Digestive Enzyme Supplementation in Gastrointestinal Diseases
por: Ianiro, Gianluca, et al.
Publicado: (2016)

Infliximab does not increase colonic cancer risk associated to murine chronic colitis
por: Lopetuso, Loris R, et al.
Publicado: (2016)

Orphan patients with inflammatory bowel disease - when we treat beyond evidence
por: Privitera, Giuseppe, et al.
Publicado: (2021)

Safety assesment of Bacillus clausii UBBC07, a spore forming probiotic
por: Lakshmi, Suvarna G., et al.
Publicado: (2017)

Protective action of Bacillus clausii probiotic strains in an in vitro model of Rotavirus infection
por: Paparo, Lorella, et al.
Publicado: (2020)

Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre
por: Scaldaferri, Franco, et al.
Publicado: (2020)

Gut and Reproductive Tract Microbiota Adaptation during Pregnancy: New Insights for Pregnancy-Related Complications and Therapy
por: De Siena, Martina, et al.
Publicado: (2021)

Bacillus clausii as adjunctive treatment for acute community-acquired diarrhea among Filipino children: a large-scale, multicenter, open-label study (CODDLE)
por: de Castro, Jo-Anne A., et al.
Publicado: (2019)

Evaluation of Two Active System Encapsulant Matrices with Quercetin and Bacillus clausii for Functional Foods
por: Enciso-Huerta, Hector Alfonso, et al.
Publicado: (2022)

Immunomodulatory and Antioxidant Properties of a Novel Potential Probiotic Bacillus clausii CSI08
por: Khokhlova, Ekaterina, et al.
Publicado: (2023)

Bariatric procedures and microbiota: patient selection and outcome prediction
por: Puca, Pierluigi, et al.
Publicado: (2021)

Wheat desensitization treatment in patients with gluten sensitivity
por: Nucera, Eleonora, et al.
Publicado: (2018)

Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab
por: Scaldaferri, Franco, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8lf6hs3j8180rpcentu9dppk9a